Arborsense

Arborsense, Inc. is commercializing patented graphene-based sensor technology for rapid, sensitive monitoring of biochemical markers. The company develops non-invasive, transdermal wearable sensors that analyze biomarkers in sweat, providing timely measurements intended to support proactive interventions and better health outcomes. Its approach offers an alternative to methods such as blood draws and urine testing.

Its products include Arborsense GRADE®, described as the first corrections-grade, wrist-worn alcohol wearable, and SCANar™, a point-of-need quantitative drug detector. SCANar uses a comfortable, watch-like sweat collection device and is presented as a private, sanitary alternative to urine testing. Arborsense offers its technology for self-directed and supervised use across compliance, research, and consumer health applications.

For compliance, its sweat-based biomonitors are intended to support accountability and safety in law enforcement, workplace settings, rehabilitation, and healthcare. Research applications include measuring biomarkers and tracking trends in substance use, metabolic health, and disease studies. Consumer monitors are designed to provide personalized insights into substance intake, metabolism, hydration, and stress. Arborsense is based in Ann Arbor, Michigan.